In an effort to shore up its credit rating, the French government has turned the financial screw on pharmaceutical manufacturers.
Continue reading "French Pharma Industry Pays The Price For Country’s Financial Woes" »
A bill in the French upper house of parliament, the Senate, aimed at averting conflicts of interest in the pharmaceutical sector now has a section that could in fact encourage conflict by creating potentially painful class action cases against firms.
Continue reading "Rx Class Action Suits May Come To France In Response To Mediator Scandal" »